Table 2.
Relationship between PSMC2 expression and tumor characteristics in patients with breast cancer.
| Features | No. of patients | PSMC2 expression | P value | |
|---|---|---|---|---|
| Low | High | |||
| All patients | 175 | 83 | 92 | |
| Age (years) | 0.072 | |||
| ≤60 | 108 | 56 | 52 | |
| >60 | 59 | 22 | 37 | |
| Tumor size | 0.020 | |||
| ≤3 cm | 87 | 45 | 42 | |
| >3 cm | 59 | 19 | 40 | |
| Grade | 0.006 | |||
| I | 1 | 0 | 1 | |
| II | 81 | 45 | 36 | |
| III | 67 | 21 | 46 | |
| T Infiltrate | 0.347 | |||
| T1 | 42 | 22 | 20 | |
| T2 | 100 | 45 | 55 | |
| T3 | 14 | 5 | 9 | |
| T4 | 1 | 1 | 0 | |
| Lymphatic metastasis (N) | 0.238 | |||
| N0 | 85 | 37 | 48 | |
| N1 | 42 | 19 | 23 | |
| N2 | 21 | 12 | 9 | |
| N3 | 12 | 7 | 5 | |
| AJCC Stage | 0.637 | |||
| 1 | 30 | 15 | 15 | |
| 2 | 88 | 37 | 51 | |
| 3 | 39 | 21 | 18 | |
| Lymphoid positive number | 0.475 | |||
| =0 | 78 | 32 | 46 | |
| >0 | 66 | 31 | 35 | |